Key Personnel

KEY PERSONNEL


john-suh-avatar

JOHN SUH, MBA

Executive Director

View More...

  • Chief Executive Officer, LegalZoom – grew company value to more than $2 Billion at his departure, making it the 12th globally largest internet-based company
  • Chief Executive Officer, Studio Direct, Internet Division Li and Fung, a worldwide supply chain manager of US and EU branded products
  • Chief Executive Officer & Co-Founder, Castling Group – launched category leaders J.Crew and Barneys, NY
  • MBA with high distinction, Harvard Business School
Sohail-3

SOHAIL R. ZAIDI, PLD, YMP

Chief Executive Officer

View More...

  • Chief Financial Officer (CFO), Intech Process Automation Inc
  • Chief Operating Officer (COO) and Executive Director, Ecopack Limited
  • Operations Manager, Imperial Chemical Industries (ICI)
  • PLD in Business Leadership, Harvard Business School
  • YMP Business Management, INSEAD, France
  • Mentor in Residence, Innovation Hub, University Of Florida
mark-rosenfeld-avatar

MARK J. ROSENFELD, M.S., Ph.D

Chief Innovation Officer

View More...

  • US Scientist, Joint United Nations FAO/IAEA Committee on Transboundary Diseases – innovated a device for the molecular detection of bird flu and other pathogens
  • Visiting Scholar, Giant Panda Conservation and Research Center, Peking University, China
  • Faculty, Molecular Biology, University of Utah School of Medicine
  • Advisor, Cannabis Legalization and Regulatory Affairs to Multiple States
Chris-2

CHRISTOPHER B.G. MOORE, BCA (Hons), ACA (New Zealand)

Senior Vice President — Corporate & Regulatory Affairs

View More...

  • President Emeritus, ANANDA Scientific
  • Senior Vice President, Global Business Services, Merck
  • Senior Vice President, Operations (Banyu Pharmaceuticals Co. Ltd.), Merck
  • Vice President, Operations (Human Health), Merck
  • Vice President, Operations (Asia Pacific), Merck
  • Vice President, Operations (Intercontinental), Merck
Ariel-1

ARIEL STRAHOVSKY, B.Che.E., M.B.A.

Managing Director Israel

View More...

  • Desk Manager, Municipal Wastewater Treatment, TAHAL Group, Israel
  • Operation Manager, Mekorot Development and Enterprise, Israel
  • Desk Manager, Wastewater Treatment, IDE Technologies, Israel
  • Project Manager, BPT (Bio Pure) Technologies, Israel
  • Graduate, Technion – Israel Institute of Technology

SCIENTIFIC ADVISORY BOARD


Nissim-1

NISSIM GARTI, M.S., Ph.D.

Scientific R&D Partner

View More...

  • Director, Casali Institute of Applied Chemistry, The Hebrew University of Jerusalem
  • Search Committee, 2013 Nobel Prize in Chemistry
  • Recipient – 2016 Herjie Award (global award for nanotechnology research excellence)
  • The Japanese Award for the Promotion of Senior Foreign Scientists
  • Ratner Chair of Chemistry of the Hebrew University
02-personnel-susan-alpert

SUSAN ALPERT, M.D., Ph.D.

Regulatory Affairs & Clinical Trials Advisor

View More...

  • Director, USFDA Office of Device Evaluation
  • Senior Vice President − Global Regulatory Affairs, Medtronic
  • Vice President − Regulatory Sciences, C.R. Baird, Inc.
  • Chairman, Regulatory Affairs Professionals Society
  • Advisory Board, Medical Technology Leadership Forum
  • Executive Committee, Clinical Trials Transformation Initiative
02-personnel-michael-dor

Michael Dor MD, MPA

Medical Advisor – Cannabinoids

View More...

  • Medical Director, Medical Cannabis Unit, Israel Health Ministry
  • Recipient, Presidential Award (highest Israel civilian honor)
  • Head, Hospitals Division, Israel Health Ministry
  • Head, General Medicine Division, Israel Health Ministry
  • Deputy Director, Health Management, Israel Health Ministry
marc-cohen-avatar

MARC M. COHEN, MBBS (Hons), PhD, FAMAC, FICAE

Wellness & Sports Medicine

View More...

  • Chairman, Wellness Program,, Royal Melbourne Institute of Technology (RMIT University), Australia
  • Director, Centre for Complementary Medicine, Institute for Health Services Research, Monash University, Australia
  • Expert Advisor, Australia Therapeutics Good Authority Complementary Medicine Evaluation Committee
02-personnel-silviu-brill

Silviu Brill MD

Phase 2 Clinical Director – Neuropathic Pain